Clinical Presentation, Management and Outcome of Japanese Patients With Acute Myocardial Infarction in the Troponin Era　– Japanese Registry of Acute Myocardial Infarction Diagnosed by Universal Definition (J-MINUET) –

Abstract

on behalf of the J-MINUET investigators Background: New criteria for diagnosis of acute myocardial infarction (AMI) were proposed in 2000 as a universal definition, in which cardiac troponin (cTn) was the preferred biomarker. A large number of patients formerly classified by creatine kinase (CK) as unstable angina are now ruled-in by cTn as non-ST-elevation myocardial infarction (NSTEMI).

Impact of Acute Kidney Injury on In-Hospital Outcomes of Patients With Acute Myocardial Infarction ― Results From the Japanese Registry of Acute Myocardial Infarction Diagnosed by Universal Definition (J-MINUET) Substudy ―

“…The design, inclusion criteria, and results of the J-MINUET study have been previously reported. 15 Briefly, AMI was diagnosed using the new universal definition, in which cardiac troponin is the preferred biomarker of myocardial injury. 16 ST-segment elevation AMI was diagnosed in the presence of new ST elevation at the J point in at least 2 contiguous leads ≥0.2 mV in men or ≥0.15 mV in women in leads V2-3, or ≥0.1 mV in another 2 contiguous leads.…”

Multicenter Cohort Study of Acute Myocardial Infarction in Korea – Interim Analysis of the Korea Acute Myocardial Infarction Registry-National Institutes of Health Registry –

“…Patients with a diagnosis of AMI at presentation to hospital have been enrolled and followed up continuously. The aims of the KAMIR-NIH are as follows: (1) to collect data on baseline clinical characteristics, current treatment patterns, and shortand long-term patient outcomes; (2) to analyze the prognostic factors of AMI; and (3) to improve the long-term prognosis of individual patients.…”

Clinical Impact of Ventricular Tachycardia and/or Fibrillation During the Acute Phase of Acute Myocardial Infarction on In-Hospital and 5-Year Mortality Rates in the Percutaneous Coronary Intervention Era

“…1- 7 Recently, PCI has become a widely used therapeutic approach for the treatment of AMI patients. 8- 10 As compared with fibrinolytic therapy, PCI has better clinical outcomes in terms of higher success rates of infarct vessel reperfusion and greater reduction of infarct area. 8 Clinically, these benefits likely result in a lower incidence of recurrent ischemia, re-infarction, and heart failure, and, consequently, an improved survival rate.…”